Plasma cholecystokinin and gallbladder responses to increasing doses of bombesin in celiac disease.
Impaired postprandial gallbladder emptying in celiac disease has been attributed to an absence of appropriate cholecystokinin release. To determine if a flat jejunal mucosa in celiac patients is related to a reduced cholecystokinin-secreting capacity, increasing doses of bombesin were infused into six patients with celiac disease and a flat jejunal mucosa (group A), in seven celiac patients with a normal jejunal mucosa while on a gluten-free diet (group B), and in seven healthy controls (group C). Bombesin induced significant (P < 0.05) increments of plasma CCK to a maximum value of 1.0 +/- 0.3 pM in group A, to 1.5 +/- 0.3 pM in group B, and to 1.2 +/- 0.3 pM in group C (NS between groups), that were accompanied by significant (P < 0.05) gallbladder emptying responses of 70 +/- 4% in group A, 47 +/- 10% in group B and 65 +/- 5% in group C. Dose-response relationships were not different between groups. We conclude that there is no major impairment of gallbladder responsiveness to bombesin or of cholecystokinin-secreting capacity in patients with a flat jejunal mucosa due to celiac disease.
Thimister
P W
PW
Department of Gastroenterology & Hepatology, University Hospital Nijmegen, The Netherlands.
Hopman
W P
WP
Rosenbusch
G
G
Jansen
J B
JB
D000328:Adult; D001839:Bombesin / Q000008:administration & dosage* / Q000494:pharmacology; D016022:Case-Control Studies; D002446:Celiac Disease / Q000473:pathology / Q000503:physiopathology*; D002766:Cholecystokinin / Q000097:blood* / Q000378:metabolism; D005260:Female; D016473:Gallbladder Emptying / Q000187:drug effects*; D006801:Humans; D007413:Intestinal Mucosa / Q000378:metabolism / Q000473:pathology; D007583:Jejunum / Q000378:metabolism / Q000473:pathology; D008297:Male; D008875:Middle Aged
D002766:Cholecystokinin; D001839:Bombesin